← Adagene Inc.
| Annual Trend | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $1.5m |
$480k
-68.24%
|
$701k
+46.02%
|
$10.2m
+1351.71%
|
$9.3m
-8.67%
|
$18.1m
+94.90%
|
$103k
-99.43%
|
$7.7m
+7332.76%
|
$7.7m
0.00%
|
|
| Net Interest Income | — | — | — | — | ($316k) |
$3.2m
+1105.40%
|
$2.9m
-7.11%
|
$1.8m
-37.59%
|
$1.8m
0.00%
|
|
| Research And Development | $16.1m | $16.2m | $33.5m | $68.1m | $81.3m | $36.6m | $28.8m | $22.0m | $22.0m | |
| General and Administrative Expense | $2.8m | $3.4m | $10.3m | $14.4m | $11.9m | $8.7m | $7.3m | $7.1m | $7.1m | |
| Operating expenses: | ||||||||||
| Other Operating Income | — | — | — | — | ($78.8m) | $3.5m | ($32.6m) | ($17.4m) | — | |
| Loss from operations | ($17.3m) |
($19.2m)
-10.59%
|
($43.2m)
-125.10%
|
($72.4m)
-67.70%
|
($83.9m)
-15.97%
|
($23.7m)
+71.74%
|
($36.0m)
-51.57%
|
($21.4m)
+40.37%
|
— | |
| Other Non Operating Income Expenses | $902k | $723k | $972k | $1.8m | $2.2m | $1.8m | $467k | $324k | — | |
| Operating Income (Loss) | ($17.3m) |
($19.2m)
-10.59%
|
($43.2m)
-125.10%
|
($72.4m)
-67.70%
|
($83.9m)
-15.97%
|
($23.7m)
+71.74%
|
($36.0m)
-51.57%
|
($21.4m)
+40.37%
|
($21.4m)
0.00%
|
|
| Interest and investment income | — | — | — | — | $378k | $4.3m | $3.8m | $2.3m | — | |
| Interest Income | — | — | — | — | $378k | $4.3m | $3.8m | $2.3m | $2.3m | |
| Net Non Operating Interest Income Expense | — | — | — | — | ($316k) | $3.2m | $2.9m | $1.8m | $1.8m | |
| Foreign Currency Transaction Gain (Loss), before Tax | $13k | $22k | ($645k) | ($603k) | $2.6m | $1.4m | ($906k) | $1.3m | — | |
| Foreign exchange gain (loss), net | $13k | $22k | ($645k) | ($603k) | $2.6m | $1.4m | ($906k) | $1.3m | — | |
| Gain On Sale Of Security | — | — | — | — | $2.6m | $1.4m | ($906k) | $1.4m | $1.4m | |
| Other income, net | $902k | $723k | $972k | $1.8m | $2.2m | $1.8m | $467k | $324k | $1.7m | |
| Interest Expense (non-operating) | $91k | $138k | $202k | $364k | $693k | $1.1m | $852k | $463k | $463k | |
| Other Income Expense | — | — | — | — | $4.7m | $3.3m | ($440k) | $1.7m | $1.7m | |
| Income (Loss) from Continuing Operations before Income Taxes, Domestic | — | — | — | — | — | — | — | ($1.6m) | ($17.9m) | |
| Pre-Tax Income | ($15.3m) | ($16.4m) | ($42.4m) | ($71.5m) | ($79.5m) | ($17.3m) | ($33.4m) | ($17.9m) | ($17.9m) | |
| Loss before income tax | ($15.3m) | ($16.4m) | ($42.4m) | ($71.5m) | ($79.5m) | ($17.3m) | ($33.4m) | ($17.9m) | — | |
| Current Income Tax Expense (Benefit) | — | — | — | $1.7m | $503k | $1.7m | ($18k) | ($298k) | ($298k) | |
| Income tax benefit (expense) | — | — | — | ($1.7m) | ($459k) | ($1.7m) | $18k | $298k | — | |
| Net Income From Continuing And Discontinued Operation | ($15.3m) | ($16.4m) | ($42.4m) | ($73.2m) | ($80.0m) | ($18.9m) | ($33.4m) | ($17.6m) | ($17.6m) | |
| Net loss attributable to Adagene Inc.'s shareholders | ($15.3m) | ($16.4m) | ($42.4m) | ($73.2m) | ($80.0m) | ($18.9m) | ($33.4m) | ($17.6m) | — | |
| Net loss attributable to ordinary shareholders | ($14.3m) | ($16.7m) | ($42.6m) | ($73.2m) | ($80.0m) | ($18.9m) | ($33.4m) | ($17.6m) | — | |
| Net Income (Loss) Available to Common Stockholders, Basic | ($14.3m) |
($16.7m)
-16.61%
|
($42.6m)
-155.69%
|
($73.2m)
-71.66%
|
($80.0m)
-9.24%
|
($18.9m)
+76.31%
|
($33.4m)
-76.41%
|
($17.6m)
+47.32%
|
($17.6m)
0.00%
|
|
| Otherunder Preferred Stock Dividend | — | — | — | $29k | $0 | $0 | — | — | — | |
| Earnings Per Share, Basic | ($0.94) | ($1.10) | ($2.67) | ($1.46) | ($1.48) | ($0.35) | ($0.59) | ($0.30) | ($0.38) | |
| Earnings Per Share, Diluted | ($0.94) | ($1.10) | ($2.67) | ($1.46) | ($1.48) | ($0.35) | ($0.59) | ($0.30) | ($0.38) | |
| Basic (in shares) | $15.2m | $15.2m | $16.0m | $50.0m | $54.1m | $54.7m | $56.3m | $59.0m | $47.2m | |
| Diluted (in shares) | $15.2m | $15.2m | $16.0m | $50.0m | $54.1m | $54.7m | $56.3m | $59.0m | $47.2m | |
| Weighted Average Number of Shares Outstanding, Basic | 15.2m | 15.2m | 16.0m | 50.0m | 54.1m | 54.7m | 56.3m | 59.0m | 47.2m | |
| Basic Average Shares | — | — | — | $40.0m | $43.3m | $43.8m | $45.0m | — | $47.2m | |
| Diluted Average Shares | — | — | — | $40.0m | $43.3m | $43.8m | $45.0m | — | $47.2m | |
| Weighted Average Number of Shares Outstanding, Diluted | 15.2m | 15.2m | 16.0m | 50.0m | 54.1m | 54.7m | 56.3m | 59.0m | 47.2m | |
| Additional Financial Items | ||||||||||
| Change in fair value of warrant liabilities | $534k | $1.2m | $0 | — | — | — | — | $48k | — | |
| Foreign currency translation adjustments, net of nil tax | ($11k) | $66k | ($6k) | $257k | ($755k) | ($951k) | $1.3m | ($1.4m) | — | |
| Diluted EPS | — | — | — | ($1.82) | ($1.85) | ($0.44) | ($0.74) | — | ($0.38) | |
| Diluted NI Availto Com Stockholders | ($15.3m) | ($16.4m) | ($42.4m) | ($73.2m) | ($80.0m) | ($18.9m) | ($33.4m) | ($17.6m) | ($17.6m) | |
| Normalized EBITDA | — | — | — | — | ($79.9m) | ($16.4m) | ($30.7m) | ($18.2m) | ($16.9m) | |
| Normalized Income | — | — | — | — | ($81.9m) | ($20.0m) | ($32.5m) | ($19.0m) | ($19.0m) | |
| Other Gand A | $2.8m | $3.4m | $10.3m | $14.4m | $11.9m | $8.7m | $7.3m | $7.1m | — | |
| Reconciled Depreciation | — | — | — | — | $1.4m | $1.2m | $939k | $590k | $590k | |
| Selling General And Administration | $2.8m | $3.4m | $10.3m | $14.4m | $11.9m | $8.7m | $7.3m | $7.1m | — | |
| Tax Effect Of Unusual Items | — | — | — | — | $639k | $362k | ($476) | $23k | $23k | |
| Tax Provision | — | — | — | — | $459k | $1.7m | ($18k) | ($298k) | ($298k) | |
| Tax Rate For Calcs | — | — | — | — | $0 | $0 | $0 | $0 | $0 | |
| Operating Expense | — | — | — | — | $93.2m | $41.8m | $36.1m | $29.1m | $29.1m | |
| Total comprehensive loss attributable to Adagene Inc.'s shareholders | ($15.3m) | ($16.4m) | ($42.4m) | ($72.9m) | ($80.7m) | ($19.9m) | ($32.2m) | ($19.0m) | — | |
| Total Unusual Items | — | — | — | — | $2.6m | $1.4m | ($906k) | $1.4m | $1.4m | |
| Total Expenses | — | — | — | — | $93.2m | $41.8m | $36.1m | $29.1m | $29.1m |